Steadylabs

0
Your Cart
empty cart Your cart is currently empty! Return to Shop
0
Your Cart
empty cart Your cart is currently empty! Return to Shop

Thymosin Alpha-1

Thymosin Alpha-1 is a synthetic 28-amino-acid peptide supplied for controlled laboratory, analytical, and scientific research.

Its defined peptide sequence includes an N-terminal acetyl modification that is part of the compound’s complete molecular identity. This structural feature should be retained when documenting molecular mass, peptide identity, and analytical characteristics.

Thymosin Alpha-1, also known as Thymalfasin, should be distinguished from other thymosin-related peptides and thymic preparations that have different sequences or compositions.

Research Applications

Thymosin Alpha-1 may be examined in controlled non-clinical research involving:

  • Peptide identity and characterization
  • Molecular interaction studies
  • Protein-binding research
  • Structure-function analysis
  • Analytical peptide comparison
  • Stability assessment
  • Non-clinical biochemical and cellular models

Any experimental findings should remain specific to the applicable research system and should not be interpreted as evidence of therapeutic, immune-related, antiviral, or clinical effectiveness.

Structural Information

Thymosin Alpha-1 consists of 28 amino-acid residues:

SDAAVDTSSEITTKDLKEKKEVVEEAEN

The commonly referenced structural form includes N-terminal acetylation:

Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN-OH

The N-terminal acetyl group contributes to the peptide’s complete molecular identity and should be included in accurate technical documentation.

Analytical Identification

Relevant analytical characterization may include:

  • Amino-acid sequence confirmation
  • N-terminal acetylation verification
  • Molecular mass assessment
  • Chromatographic purity testing
  • Peptide identity verification
  • Structural characterization
  • Lot-specific quality analysis

If the material is supplied as an acetate or another salt/counter-ion form, final molecular specifications should be aligned with that exact preparation.

Specifications & Documentation

Lot-specific documentation should be reviewed for:

  • Compound identity
  • Amino-acid sequence
  • Terminal modification
  • Molecular formula
  • Molecular weight
  • Salt or counter-ion form
  • Purity specification
  • Analytical testing
  • Lot or batch information
  • Certificate of Analysis
  • Storage requirements

Authenticated product-specific documentation takes precedence over general reference information.

Storage & Handling

Store according to the conditions specified on the product label and Certificate of Analysis. Protect the material from environmental conditions that could compromise peptide integrity.

Follow established laboratory procedures appropriate for research materials.

Research Use Only

Thymosin Alpha-1 is supplied exclusively for laboratory research, analytical testing, and scientific reference purposes.

Disclaimer

For research use only. Not for human or veterinary use. Not intended for consumption, administration, immune-related use, antiviral use, diagnosis, treatment, mitigation, cure, or prevention of any disease. No therapeutic, immune-related, antiviral, medical, or clinical claims are made or implied. Product information is supplied solely for scientific identification, documentation, and research reference.

$ 90

Thymosin Alpha-1 is a synthetic 28-amino-acid peptide supplied for controlled laboratory, analytical, and scientific research.

Its defined peptide sequence includes an N-terminal acetyl modification that is part of the compound’s complete molecular identity. This structural feature should be retained when documenting molecular mass, peptide identity, and analytical characteristics.

Thymosin Alpha-1, also known as Thymalfasin, should be distinguished from other thymosin-related peptides and thymic preparations that have different sequences or compositions.

Research Applications

Thymosin Alpha-1 may be examined in controlled non-clinical research involving:

  • Peptide identity and characterization
  • Molecular interaction studies
  • Protein-binding research
  • Structure-function analysis
  • Analytical peptide comparison
  • Stability assessment
  • Non-clinical biochemical and cellular models

Any experimental findings should remain specific to the applicable research system and should not be interpreted as evidence of therapeutic, immune-related, antiviral, or clinical effectiveness.

Structural Information

Thymosin Alpha-1 consists of 28 amino-acid residues:

SDAAVDTSSEITTKDLKEKKEVVEEAEN

The commonly referenced structural form includes N-terminal acetylation:

Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN-OH

The N-terminal acetyl group contributes to the peptide’s complete molecular identity and should be included in accurate technical documentation.

Analytical Identification

Relevant analytical characterization may include:

  • Amino-acid sequence confirmation
  • N-terminal acetylation verification
  • Molecular mass assessment
  • Chromatographic purity testing
  • Peptide identity verification
  • Structural characterization
  • Lot-specific quality analysis

If the material is supplied as an acetate or another salt/counter-ion form, final molecular specifications should be aligned with that exact preparation.

Specifications & Documentation

Lot-specific documentation should be reviewed for:

  • Compound identity
  • Amino-acid sequence
  • Terminal modification
  • Molecular formula
  • Molecular weight
  • Salt or counter-ion form
  • Purity specification
  • Analytical testing
  • Lot or batch information
  • Certificate of Analysis
  • Storage requirements

Authenticated product-specific documentation takes precedence over general reference information.

Storage & Handling

Store according to the conditions specified on the product label and Certificate of Analysis. Protect the material from environmental conditions that could compromise peptide integrity.

Follow established laboratory procedures appropriate for research materials.

Research Use Only

Thymosin Alpha-1 is supplied exclusively for laboratory research, analytical testing, and scientific reference purposes.

Disclaimer

For research use only. Not for human or veterinary use. Not intended for consumption, administration, immune-related use, antiviral use, diagnosis, treatment, mitigation, cure, or prevention of any disease. No therapeutic, immune-related, antiviral, medical, or clinical claims are made or implied. Product information is supplied solely for scientific identification, documentation, and research reference.

Reviews

There are no reviews yet.

Be the first to review “Thymosin Alpha-1”

Your email address will not be published. Required fields are marked *

Related Products

// FAQ's //

Current Offers on Selected Research Materials Materials

Review active pricing on selected Research Materials for Laboratory Use while product availability and promotional terms remain in effect.

No. All products are supplied exclusively for laboratory research. They are not intended for human or veterinary use, personal use, diagnostic procedures, or therapeutic applications.

Yes. Our checkout process uses secure technology to help protect your personal and payment information. Available payment methods may vary depending on your location and order details.

Relevant product pages may include recommended Storage Conditions and Handling Guidelines. Researchers remain responsible for using appropriate equipment, facilities, procedures, and internal laboratory controls.

Eligible customers may Order Research Compounds Online, subject to product availability, location restrictions, website terms, and any applicable order-verification requirements.

No. Steady labs does not provide patient consultations, medical advice, dosing guidance, treatment recommendations, or instructions for personal use.

Research grade describes material supplied for controlled laboratory investigation with relevant specifications or available analytical information. It does not indicate pharmaceutical approval, suitability for consumption, or authorization for clinical use.

error: Content is protected !!
Scroll to Top